.
"we were quite surprised to find there were no significant differences," says study author
.
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.
.
of all car-t cell trials registered since 2001, more than half are being conducted in china.
.
.
.